CoChat
Sign Up
Cited by 140Vestibular and auditory disordersCardiovascular Syncope and Autonomic DisordersPsychosomatic Disorders and Their Treatments

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

A Prospective Trial of Sertraline for Chronic Subjective Dizziness

Staab, Jeffrey P., Ruckenstein, Michael J., Amsterdam, Jay D.·2004·The Laryngoscope
DOI 10.1097/00005537-200409000-00025
Open this paper in CoChat — free account

Abstract

OBJECTIVES/HYPOTHESIS: The authors previously reported that selective serotonin reuptake inhibitors (SSRIs) reduce chronic subjective dizziness in patients with and without psychiatric illnesses. To extend those preliminary findings and test the hypothesis that SSRIs may offer a novel treatment for chronic subjective dizziness, the authors conducted a prospective study of sertraline in patients with dizziness for more than 6 months, in the absence of active physical neurotologic illness. STUDY DESIGN: Sixteen-week, prospective, open-label, flexible-dose clinical trial. METHODS: Twenty-four patients with subjective dizziness for more than 6 months and no active physical neurotologic illness were studied. Eighteen patients had major anxiety disorders. Six had minor frustration or worry that did not warrant a psychiatric diagnosis. Sertraline was administered at a daily dose of 25 mg, which was increased to a maximum daily dose of 200 mg. Dizziness, functional impairment, and psychological distress were measured using the Dizziness Handicap Inventory (DHI) and Brief Symptom Inventory-53 (BSI-53). Treatment outcomes were analyzed using repeated-measures multivariate analyses of variance, with last observations carried forward. RESULTS: Three patients were excluded from data analysis for disqualifying medical conditions, one for protocol violations. Fifteen (75%) patients completed treatment. Five (25%) withdrew for adverse effects or lack of efficacy. The median daily dose of sertraline was 100 mg. Sertraline significantly reduced scores on all three DHI subscales and the BSI-53. Eleven of 15 (73%) patients who completed treatment had a positive response, including 8 of 11 (73%) with major anxiety disorders and 3 of 4 (75%) with no psychopathological conditions. Six patients enjoyed a full remission of symptoms. CONCLUSION: Sertraline significantly reduced chronic subjective dizziness in patients without active physical neurotologic illness, including those with and without psychiatric comorbidity.

Overview

Integrity signals

Registry

Crossref · 10.1097/00005537-200409000-00025

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 3

  1. Lopez Gentili LI, 2003, Database for patients with balance disorders, Rev Neurol, 36, 960
  2. First MB, 1994, Structured Clinical Interview for Axis I DSM‐IV Disorders: Patient Edition
  3. 10.1111/j.2044-8341.1959.tb00467.x · DOI · Paper page

Cited by

Sorted by citations

See all 140

Related

See all

Metadata

Authors
Staab, J. P., Ruckenstein, M. J., & Amsterdam, J. D.
Affiliations
University of Pennsylvania Health System (US)
Corresponding author
Staab, Jeffrey P.
ORCID
Staab, Jeffrey P.
Venue
The Laryngoscope
Publisher
Wiley
Published
2004-09
Volume
114
Issue
9
Pages
1637-1641
ISSN
  • 0023-852X (ISSN-L)
  • 1531-4995
DOI
10.1097/00005537-200409000-00025
OpenAlex
W2101574717
Cited by
140
References
15
Citations by year
2026: 7 · 2025: 8 · 2024: 8 · 2023: 20 · 2022: 6 · 2021: 14 · 2020: 9 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 10 · 2015: 2 · 2014: 3 · 2013: 2 · 2012: 5
FWCI
3.14
Type
journal article
Language
en
Open access
closed
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor, 1585 d)
Locations
  • The Laryngoscope (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords
sertraline, selective serotonin reuptake inhibitors, anxiety disorders, psychiatric comorbidity, Dizziness Handicap Inventory, psychological distress, functional disability, symptom remission
MeSH terms
Adult, Anxiety Disorders, Chronic Disease, Dizziness, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Prospective Studies, Somatoform Disorders, Stress, Psychological, Treatment Outcome, Selective Serotonin Reuptake Inhibitors, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review